交易中 03-26 10:29:05 美东时间
+1.740
+2.83%
今日重点评级关注:HC Wainwright & Co.:维持OCUGEN"买入"评级,目标价从7美元升至10美元;HC Wainwright & Co.:维持Maze Therapeutics"买入"评级,目标价从60美元升至110美元
今天 11:41
Shares of oil-related companies are trading lower after President Trump announc...
03-24 00:09
今日重点评级关注:韦德布什:维持Black Diamond Therapeutic"跑赢大市"评级,目标价从13美元升至14美元;花旗:维持Olema Pharmaceuticals"买入"评级,目标价从60美元升至62美元
03-18 10:48
今日重点评级关注:Freedom Capital Markets:维持LifeMD"买入"评级,目标价从8美元升至10美元;Chardan Capital:维持Opus Genetics"买入"评级,目标价从9美元升至11美元
03-13 09:59
Shares of oil refining-related companies are trading higher after the Internati...
03-11 23:02
• Geopolitical tensions boosted crude oil prices and energy sector sentiment. • MPC reported strong Q4 and full-year 2025 earnings exceeding estimates. • Analysts maintain a "Buy" rating with an average price target of $200.06.
03-04 17:15
华盛资讯2月26日讯,Par Pacific Holdings公布2025财年年度业绩,公司年度营收74.65亿美元,同比下降6.4%,归母净利润3.69亿美元,扭亏为盈。
02-26 08:18
Par Pacific Q4 revenue beats expectations Overview Energy company's Q4 revenue beat analyst expectations Adjusted EPS for Q4 missed analyst expectations Company repurchased 0.7 mln shares in Q4, reducing shares outstanding by 10% Outlook Company did not provide specific guidance for future quarters
02-25 05:49
Par Pacific Holdings shares are trading lower after the company reported mixed ...
02-25 05:32
Par Pacific Hldgs (NYSE:PARR) reported its Q4 earnings results on Tuesday, Febr...
02-25 05:18